Core Viewpoint - Fujian Pharmaceutical (300497.SZ) has established a new subsidiary, Weiran Alliance (Shanghai) Food Technology Co., Ltd., with a registered capital of 10 million yuan, aiming to leverage its location in the Yangtze River Delta to create a unique commercial entity for technology transfer in the protein industry [1] Group 1 - The new subsidiary has completed its business registration and obtained a business license from the Shanghai Xuhui District Market Supervision Administration [1] - The establishment of Weiran Alliance aims to build the "Weiran New Protein Co-Creation Alliance," focusing on brand building, product development, and customized marketing for member brands [1] - The initiative will initially attract overseas brands, with plans to incorporate domestic brands as new protein food materials gain recognition and approval in China, creating a dual-market synergy [1]